However, NASH, a complex disease driven by multiple mechanisms, is proving to be a challenge
GLP-1 microdosing involves using precisely calibrated smaller doses that maintain therapeutic effectiveness while dramatically reducing unwanted side effects
Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles
Our recent channel checks with clinicians highlight Resmed continues to be very well positioned to capitalise on the growth opportunity and is now unquestionably the market leader in the sector growing above market and what we consider a sustainable competitive advantage through its distribution and product offering
Bortolussi S, Catucci G, Gilardi G, Sadeghi SJ